Forecast & RatingOnly 1 analyst currently covers Paranovus ENT Tech (PAVS.US), with a price target of $7200002.88 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Jun 29, 2026; this does not constitute investment advice.
Aug 4, 2021Price forecast
$7200002.88156521701.74%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
No data available at the moment
Analyst ratings
No data available at the moment
Source: S&P Global
This information is for reference only and is not investment advice.